0001209191-20-001632.txt : 20200106 0001209191-20-001632.hdr.sgml : 20200106 20200106150035 ACCESSION NUMBER: 0001209191-20-001632 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200102 FILED AS OF DATE: 20200106 DATE AS OF CHANGE: 20200106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Meyer Colin John CENTRAL INDEX KEY: 0001662392 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37785 FILM NUMBER: 20509298 MAIL ADDRESS: STREET 1: C/O REATA PHARMACEUTICALS, INC. STREET 2: 2801 GATEWAY DR. SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001358762 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113651945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5320 LEGACY DRIVE CITY: PLANO STATE: TX ZIP: 75024 BUSINESS PHONE: 972-865-2219 MAIL ADDRESS: STREET 1: 5320 LEGACY DRIVE CITY: PLANO STATE: TX ZIP: 75024 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-01-02 0 0001358762 REATA PHARMACEUTICALS INC RETA 0001662392 Meyer Colin John 5320 LEGACY DRIVE PLANO TX 75024 0 1 0 0 Chief Medical Officer Employee Stock Option (right to buy) 207.20 2020-01-02 4 A 0 25000 0.00 A 2030-01-02 Class B common stock 25000 25000 D The options vest in sixteen equal quarterly installments beginning on April 2, 2020, subject to continued service through each vesting date. The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date. /s/ Tracy Herson, attorney-in-fact 2020-01-06